I think its best if posters carry out their own research using whatever reference material they wish. If anyone is able to challenge FSS findings then please post it up.
If you want something to get you going:
https://en.wikipedia.org/wiki/Low_copy_number
https://www.promega.co.uk/resources/profiles-in-dna/2010/what-is-lcn-definitions-and-challenges/
...snip ....
How did you get on with the following paragraph, did you understand it?
"LCN DNA (also now termed low template DNA or LT DNA) may refer to any situation where a small amount of DNA is present in a sample based on the sample type (e.g., an item that has been handled) and/or the estimated quantity of DNA determined using routine quantification assays. Samples containing <100–200 pg of total DNA available for amplification fall into the range generally considered to be LCN DNA by most practitioners. Consequently, these samples may undergo LCN DNA-testing procedures developed to increase assay sensitivity; commonly this includes increased PCR cycles (e.g., 28 cycles increased to 31 or 34 cycles) but may include other sensitivity-enhancing techniques such as desalting or concentrating products prior to electrophoresis, reducing amplification volumes, increasing injection times during electrophoresis, using high-purity formamide, etc. More recently, LCN has been used to refer to any DNA sample or DNA profile where stochastic effects (e.g., allele and locus drop-out, heterozygous peak height imbalance and elevated stutter peaks) are likely present and/or where the alleles detected are below a laboratory-defined stochastic threshold (see accompanying article by Dr. John Butler for further discussion). Regardless of whether a quantitative-, technological- and/or qualitative profile-based definition is used, the term LCN or LT DNA generally refers to any situation where: 1) the amount of DNA available for amplification is limited due to small sample size or other factors (e.g., DNA degradation, PCR inhibition), and 2) interpreting the resulting DNA profile may require more considerations than interpreting single-source or mixed DNA profiles generated using higher amounts of DNA due to the potential for incomplete DNA profiles. Other rarely recognized definitions have arisen in court documentation (e.g., quantity of DNA on a slot blot quantitation assay, any amount of DNA below the manufacturer’s recommendations)."